申请人:Janssen Pharmaceutica N.V.
公开号:US05212192A1
公开(公告)日:1993-05-18
The present invention relates to novel 6-aryl-5,6-dihydroimidazo[2,1-b]thiazole derivatives having immunostimulating properties, which are useful for treating humans and warm-blooded animals suffering from disorders and/or diseases wherein the immune system is impaired or suppressed. Processes of preparing said novel compounds and compositions containing the same as active ingredient.
本发明涉及具有免疫刺激性能的新型6-芳基-5,6-二氢咪唑[2,1-b]噻唑衍生物,用于治疗免疫系统受损或受抑制的人类和温血动物患有疾病和/或疾病的情况。制备所述新型化合物的方法以及含有其作为活性成分的组合物。